Access Statistics for Fabio Pammolli

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development 0 0 0 0 1 2 3 221
A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development 0 0 0 52 0 0 2 229
A Comparison of U.S. And European University-Industry Relations in the Life Sciences 0 0 0 0 0 1 5 394
A Comparison of U.S. and European University-Industry Relations in the Life Sciences 0 0 0 65 0 2 3 343
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence 0 0 0 10 0 0 0 80
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence 0 0 0 4 0 0 0 40
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment 0 0 0 5 0 1 3 85
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment 0 0 0 3 0 0 0 65
A Public-Private Insurance Model for Natural Risk Management: an Application to Seismic and Flood Risks on Residential Buildings in Italy 0 1 1 12 0 2 10 26
Access to Medicines and European Market Integration 0 0 0 31 0 0 3 83
Alcuni vantaggi "minori" del contributivo: Ricongiunzione e Totalizzazione 0 0 1 8 0 0 1 75
Assessing financial distress dependencies in OTC markets: a new approach by Trade Repositories data 0 0 0 26 0 0 1 55
Auctions vs. Bargaining: An Empirical Analysis of Medical Device Procurement 0 0 0 149 0 0 0 498
Better to stay apart: asset commonality, bipartite network centrality, and investment strategies 0 0 1 5 0 0 16 57
Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks 0 0 1 24 0 0 2 145
Co-evolution of Organizational Forms and Technology 0 0 0 0 0 0 1 249
Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry 0 0 0 234 0 0 0 457
Crescita, occupazione e sostenibilità - Il ruolo delle infrastrutture digitali 0 0 0 13 0 1 1 86
Demography, Sustainability, and Growth Notes on the future of the European "Social Market" Economy 0 0 0 47 0 0 1 141
Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dell'Italia nel contesto europeo 0 0 0 56 0 0 0 189
Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure 0 0 1 150 0 0 2 513
Federalismo e riparto del Fsn-2011: Much Ado About Nothing? 0 0 0 15 0 0 5 180
Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN 0 0 0 16 0 0 1 98
Gli andamenti della spesa sanitaria: l'Italia in una sintetica comparazione internazionale 0 0 0 21 0 0 0 78
Global Competitiveness in Pharmaceuticals: A European Perspective 0 0 8 146 1 3 20 450
Global ownership and corporate control networks 1 1 2 53 1 3 8 160
I Farmaci Oncologici in Italia: innovazione e sostenibilità economica 0 0 1 54 0 0 5 236
I farmaci ospedalieri tra Europa, Stato, Regioni e Cittadini 0 0 0 17 0 0 0 103
I numeri del Federalismo in Sanità - Benchmark e Standard per la Sanità Italiana, in attesa della decretazione attuativa della Legge n. 42-2009 0 0 0 16 0 0 1 97
I numeri del Federalismo in Sanità - Benchmarking e Standard su profili di spesa sanitaria per età 0 0 1 46 0 0 3 138
I numeri del federalismo: una simulazione per la sanità 0 0 0 10 0 1 2 76
I trend della spesa sanitaria e le ragioni del finanziamento multipillar con componente ad accumulazione reale 0 0 0 12 0 0 1 108
Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato 0 0 0 14 0 0 0 113
Il disegno delle nuove agevolazioni fiscali alla previdenza complementare - una quantificazione per un lavoratore dipendente neoassunto del settore privato 0 1 1 9 0 1 6 60
Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico 0 0 0 23 1 1 2 142
In attesa del federalismo compiuto: LEA, spesa sanitaria e risorse finanziarie a livello regionale 0 0 0 20 0 0 1 98
Inflazione, bassa crescita, Euro forte: tra problemi europei ed economia globale 0 0 0 14 0 0 1 94
Innovation and Corporate Dynamics: A Theoretical Framework 0 0 0 67 0 1 2 129
Innovation and Corporate Dynamics: A Theoretical Framework 0 0 0 151 0 0 1 260
Innovation and Corporate Growth in the Evolution of the Drug Industry 0 0 1 431 1 1 6 983
Introduzione. Liberalizzazioni e concorrenza in Italia 0 0 0 26 0 1 3 147
L'integrazione pubblico-privato in sanità e assistenza alla persona 0 0 0 17 0 0 2 98
La Riforma del Welfare, il Paygo, i nuovi Ammortizzatori per il Mercato del Lavoro 0 0 0 12 0 1 2 112
La Sostenibilità dei Sistemi Sanitari Regionali 0 0 0 32 0 0 0 132
La Sostenibilità dei Sistemi Sanitari Regionali - SaniMod-Reg 2012-2030 0 0 0 31 0 0 1 133
La distribuzione al dettaglio dei farmaci - tra regolazione efficiente e mercato 0 1 2 32 1 4 6 279
La nuova fiscalità della previdenza complementare per il lavoratore, l'impresa e l'Erario - Una quantificazione per il lavoratore dipendente neoassunto del settore privato con turnover decennale di datore di lavoro 0 0 0 16 0 0 2 80
La regolamentazione delle farmacie in Italia 0 0 0 23 0 0 0 116
La sanità in Italia - tra federalismo, regolazione dei mercati e sostenibilità delle finanze pubbliche 0 2 3 27 0 2 5 111
La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica 0 0 0 17 0 0 0 74
La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale 0 0 1 16 1 1 2 120
La spesa sanitaria delle Regioni in Italia - Saniregio 2015 0 0 0 76 0 1 4 289
La spesa sanitaria delle Regioni in Italia - Saniregio 3 0 0 0 58 0 1 2 221
La spesa sanitaria delle Regioni in Italia - Saniregio2017 0 2 4 61 0 3 11 209
La spesa sanitaria pubblica in Italia: dentro la "scatola nera" delle differenze regionali - Il modello SaniRegio 0 1 6 146 1 4 18 402
Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011 0 0 1 59 1 1 3 211
Le differenze regionali nella governance della spesa sanitaria. La sanità alla sfide del federalismo: il modello SaniRegio di CeRM 0 0 0 17 0 1 5 105
Le proiezioni della spesa sanitaria Ssn - SaniMod 2011-2030 0 1 1 59 0 1 1 221
Le proiezioni di lungo periodo della spesa sociale nell'UE: l'impatto demografico e il possibile impatto della tecnologia sulla spesa sanitaria 0 0 2 20 0 0 3 104
Market Structure and Drug Innovation 0 0 0 30 0 2 5 143
Medical Devices Competitiveness and Impact on Public Health Expenditure 0 0 1 190 1 5 13 782
Medical Devices: Competitiveness and Impact on Public Health Expenditure 0 0 0 33 0 1 4 179
Mezzogiorno d'Italia - Primo Baedeker dello sviluppo territoriale e regionale 0 0 1 19 0 0 3 99
Networks Dynamics in the Pharmaceutical Industry 0 0 0 1 0 0 0 254
Networks of innovators within and across borders. Evidence from patent data 0 0 0 114 1 2 4 247
Nuove politiche per l'innovazione nel settore delle scienze della vita 0 0 1 7 0 0 1 97
Occupazione, produttività e demografia: le sfide per la crescita del Mezzogiorno - Riforme strutturali per dare basi al federalismo 0 0 0 8 0 0 1 73
On Firm Growth in Networks 0 0 1 20 0 0 1 112
On Size and Growth of Business Firms 0 0 0 35 0 1 4 340
Opting-out previdenziale, smobilizzo del TFR e basi strutturali del pilastro privato 0 1 1 9 0 1 1 70
Patent Disclosure and R&D Competition in Pharmaceuticals 0 0 0 110 1 2 3 196
Patent Disclosure and R&D Competition in Pharmaceuticals 0 0 0 117 0 0 4 322
Patent Value and R&D Competition 0 0 0 2 0 0 0 106
Peer-Group Detection of Banks and Resilience to Distress 0 0 0 13 0 0 1 65
Preferential attachment and growth dynamics in complex systems 0 0 0 19 0 1 2 115
Processes of corporate growth in the evolution of an innovation-driven industry. The case of pharmaceuticals 0 0 0 251 0 0 1 524
Quali Regole per la Spesa Farmaceutica? - Criticità, Impatti, Proposte 0 0 1 11 1 3 5 59
R&D, Within and Between Patent Competition in the Pharmaceutical Industry 0 0 1 174 0 0 3 374
Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica 0 0 0 16 1 1 3 115
Regole pensionistiche e incentivi al prolungamento della vita lavorativa: analisi del caso italiano 0 1 2 22 0 1 5 92
Regole pensionistiche e prolungamento dell'attività: analisi del TIR e effetti del cumulo lavoro-pensione 0 0 0 12 0 0 1 93
Spesa sanitaria, demografia, governance istituzionale - Tra trend storici e proiezioni a lungo termine 0 0 0 10 0 0 0 74
Statistical Properties of Business Firms Structure and Growth 0 1 1 19 1 3 3 87
Structure of Business Firm Networks and Scale-Free Models 0 0 0 53 0 0 1 238
Structure of Business Firm Networks and Scale-Free Models 0 0 0 11 0 0 0 95
Strumenti di regolazione del mercato farmaceutico: un'analisi ragionata 1 2 7 76 1 4 16 222
Systemic importance of financial institutions: from a global to a local perspective? A network theory approach 0 0 0 93 0 0 1 133
Systemic importance of financial institutions: regulations, research, open issues, proposals 0 0 0 50 0 0 1 204
Systemic risk and banking regulation: some facts on the new regulatory framework 0 0 0 137 0 0 0 223
Technological Regimes and the Growth of Networks An Empirical Analysis 0 0 0 129 0 0 1 356
The Accounting Network: how financial institutions react to systemic crisis 0 0 0 27 0 1 1 35
The Growth of Business Firms: Theoretical Framework and Empirical Evidence 0 0 1 169 1 1 3 1,659
The Growth of Business Firms: Theoretical Framework and Empirical Evidence 0 0 0 21 0 2 2 123
The Multipillar System for Health Care Financing: Thirteen Good Reasons for Open Capitalisation Funds, Covering both Pension and Health Care Provisions 0 0 0 32 0 0 1 102
The Nature and the Extent of the Market for Technology in Biopharmaceuticals 0 0 0 47 0 0 1 187
The Size Variance Relationship of Business Firm Growth Rates 0 0 0 37 0 0 2 103
The Size Variance Relationship of Business Firm Growth Rates 0 0 0 28 0 1 1 80
The Size Variance Relationship of Business Firm Growth Rates 0 0 0 33 0 0 1 93
The Sustainability of European Health Care Systems: Beyond Income and Ageing 0 0 0 3 0 0 1 46
The Sustainability of European Health Care Systems: Beyond Income and Ageing 0 0 1 59 0 1 2 200
The Value of Failures in Pharmaceutical R&D 0 0 0 33 0 0 2 149
The evolution of networks of innovators within and across borders: Evidence from patent data 0 0 0 149 0 1 9 231
The potential costs of Longevity Risk on Public Pensions. Evidence from Italian data 0 0 0 40 0 1 3 64
The productivity crisis in pharmaceutical R&D 1 1 1 180 2 2 5 513
Transition drivers and crisis signaling in stock markets 0 0 0 41 0 1 2 35
Who is this, who enters there? - Migration in Italy and its effect on fiscal sustainability and pensions 0 0 0 111 1 1 2 296
Total Working Papers 3 16 59 5,575 20 80 315 20,803


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development 0 0 1 41 1 2 6 169
A Comparison of Game-Theoretic Models for Parallel Trade 0 1 1 5 0 2 4 29
A Comparison of U.S. and European University-Industry Relations in the Life Sciences 0 0 0 15 0 0 0 120
A behavioral approach to instability pathways in financial markets 0 0 0 0 1 1 1 9
A generalized preferential attachment model for business firms growth rates 0 0 0 6 1 3 3 20
A generalized preferential attachment model for business firms growth rates 0 0 0 6 0 0 1 33
Assessing financial distress dependencies in OTC markets: a new approach using trade repositories data 0 0 0 12 1 1 1 79
Banks’ business strategies on the edge of distress 0 0 0 3 1 1 4 26
Better to stay apart: asset commonality, bipartite network centrality, and investment strategies 0 0 2 7 0 0 3 26
Climate change and financial stability: Natural disaster impacts on global stock markets 1 3 13 36 5 12 43 99
Commodity prices co-movements and financial stability: A multidimensional visibility nexus with climate conditions 1 1 7 31 1 1 12 90
Dynamic competition in pharmaceuticals 0 0 0 11 0 0 0 40
Economic and social consequences of human mobility restrictions under COVID-19 0 1 3 31 0 1 7 162
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 0 0 0 20 0 0 1 103
Financial crises: Uncovering self-organized patterns and predicting stock markets instability 0 0 1 11 0 0 4 34
Financial earthquakes: SARS-CoV-2 news shock propagation in stock and sovereign bond markets 0 0 1 5 0 0 1 12
Innovation and Corporate Dynamics: A Theoretical Framework 0 0 0 10 0 0 1 50
Innovation and corporate growth in the evolution of the drug industry 1 1 4 161 1 1 9 564
Intellectual property, technological regimes and market dynamics 0 0 0 16 1 1 1 56
Intragenerational redistribution in a funded pension system 0 0 1 16 1 2 7 79
La distribuzione dei farmaci tra progetti di riforma e incertezze 0 0 0 22 0 0 2 186
Learning from successes and failures in pharmaceutical R&D 0 0 2 24 2 2 5 113
Long-term correlations in short, non-stationary time series: An application to international R&D collaborations 0 0 0 1 0 0 1 11
Methods to account for citation inflation in research evaluation 0 0 0 4 0 1 5 49
On Innovation, Instability, and Growth. A Review and an Interpretative Framework 0 0 0 8 0 0 0 37
On firm growth in networks 0 0 0 69 0 0 1 181
On size and growth of business firms 0 1 2 10 1 2 3 35
On the size distribution of business firms 0 1 1 83 0 1 4 258
Patent disclosure and R&D competition in pharmaceuticals 0 0 1 70 0 0 3 320
Spatial heterogeneity in non-parametric efficiency: An application to Italian hospitals 0 0 0 2 0 0 1 19
Technological Regimes and the Growth of Networks: An Empirical Analysis 0 0 1 31 0 0 2 124
Technological change and network dynamics: Lessons from the pharmaceutical industry 0 1 2 183 0 2 8 507
The Accounting Network: How Financial Institutions React to Systemic Crisis 0 0 0 0 0 0 1 7
The Evolution of Knowledge and the Dynamics of an Industry Network 0 0 0 78 0 0 0 416
The Growth of Business Firms: Facts and Theory 0 0 0 114 0 0 1 660
The changing boundaries of system companies 0 0 0 3 0 0 1 30
The economic impact of structural and Cohesion Funds across sectors: Immediate, medium-to-long term effects and spillovers 0 1 3 7 0 1 5 25
The evolution of networks of innovators within and across borders: Evidence from patent data 0 0 1 17 0 1 3 75
The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis 1 1 1 49 1 1 3 143
The memory of science: Inflation, myopia, and the knowledge network 0 0 1 3 0 0 2 25
The network origins of Schumpeterian innovation 0 0 0 2 0 0 1 11
The price of pharmaceutical products in Italy. On some recent trends 0 0 0 12 0 0 1 37
The sustainability of European health care systems: beyond income and aging 0 0 0 24 0 0 0 106
Welfare and research and development incentive effects of uniform and differential pricing schemes 0 0 0 1 0 0 1 3
Total Journal Articles 4 12 49 1,260 18 39 163 5,178


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Resilience and Digital Disruption 0 0 0 0 0 0 0 5
The Rise and Fall of Business Firms 0 0 0 0 0 1 9 45
Total Books 0 0 0 0 0 1 9 50


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Digital Manufacturing and the Transformation of the Automotive Industry 0 0 0 0 0 1 2 12
Digital Technologies and Industrial Transformations 0 0 0 1 0 1 4 13
Introduction 0 0 0 0 0 0 1 1
Participation in Global Supply Chains and the Offshorability of Italian Jobs 0 0 0 0 0 0 0 3
Public Research and Industrial Innovation: A Comparison of US and European Innovation Systems in the Life Sciences 0 0 0 12 0 0 1 29
Technological Paradigms and the Evolution of Networks: Lessons from the Pharmaceutical Industry 0 0 0 8 0 0 1 29
The Way Ahead Towards Advanced Automation: Policy Implication for Core Italian Manufacturing Regions 0 0 0 0 0 1 2 5
Total Chapters 0 0 0 21 0 3 11 92


Statistics updated 2025-06-06